Terminal deletion of chromosome 13 in a fetus with normal NIPT: The added value of invasive prenatal diagnosis in the NIPT era
暂无分享,去创建一个
[1] K. Yan,et al. Pilot study of a novel multi‐functional noninvasive prenatal test on fetus aneuploidy, copy number variation, and single‐gene disorder screening , 2019, Molecular genetics & genomic medicine.
[2] F. Grati,et al. Noninvasive screening by cell‐free DNA for 22q11.2 deletion: Benefits, limitations, and challenges , 2019, Prenatal diagnosis.
[3] F. Grati,et al. Genome‐wide non‐invasive prenatal screening for all cytogenetically visible imbalances , 2018, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[4] H. Peeters,et al. Predicting fetoplacental chromosomal mosaicism during non‐invasive prenatal testing , 2018, Prenatal diagnosis.
[5] D. Oepkes,et al. Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: results of the TRIDENT study , 2017, Genetics in Medicine.
[6] M. Plana,et al. Analysis of cell‐free DNA in maternal blood in screening for aneuploidies: updated meta‐analysis , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[7] Amin R. Mazloom,et al. Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases , 2017, Genetics in Medicine.
[8] B. Faas,et al. Clinical utility of non‐invasive prenatal testing in pregnancies with ultrasound anomalies , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[9] Zhi-bin Niu,et al. Chromosome 13q deletion syndrome involving 13q31-qter: A case report , 2017, Molecular medicine reports.
[10] D. Grosu,et al. Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants. , 2016, American journal of obstetrics and gynecology.
[11] D. Grosu,et al. Clinical Validation of a Non-Invasive Prenatal Test for Genome-Wide Detection of Fetal Copy Number Variants , 2015, bioRxiv.
[12] P. Klaritsch,et al. Cell-Free DNA Testing for Fetal Chromosomal Anomalies in clinical practice: Austrian-German-Swiss Recommendations for non-invasive prenatal tests (NIPT) , 2015, Ultraschall in der Medizin.
[13] John Tynan,et al. Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts , 2015, Prenatal diagnosis.
[14] H. Peeters,et al. Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management , 2015, European Journal of Human Genetics.
[15] A. Oliphant,et al. Gestational age and maternal weight effects on fetal cell‐free DNA in maternal plasma , 2013, Prenatal diagnosis.
[16] I. Janssen,et al. Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells , 2012, Expert opinion on biological therapy.
[17] Geert Vandeweyer,et al. CNV-WebStore: Online CNV Analysis, Storage and Interpretation , 2011, BMC Bioinformatics.
[18] S. Gimelli,et al. 13q Deletion and central nervous system anomalies: further insights from karyotype–phenotype analyses of 14 patients , 2006, Journal of Medical Genetics.
[19] D. Warburton,et al. Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila odd-paired , 1998, Nature Genetics.
[20] E. Grace,et al. The 13q- deletion syndrome. , 1971, Journal of medical genetics.